-
-
Name
- Lotilibcin(WAP-8294A2)
-
Sequence
- cyclo[D-Asn-D-Trp-D-Orn-N(Me)Val-ObAla(3R-isohexyl)-Ser-D-Asn(3R-OH)-Ser-Gly-D-N(Me)Phe-Leu-D-Orn-Gl
-
Description
- Lipodepsipeptide
-
-
Target Organism
-
- No MICs found on DRAMP database
-
Reference
-
- Systematic optimization for production of the anti-MRSA antibiotics WAP-8294A in an engineered strain of Lysobacter enzymogenes.(PMID: 31520522)
-
Medical use
- Methicillin-resistant S. aureus
-
Company
- aRigen Pharmaceuticals, Green Cross Corporation
-
Stage of Development
- Phase I/II
-
-
Clinical Trials
- Not listed